31 research outputs found
Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/92443/1/bjh9173.pd
One bright star
One Bright Star was commissioned by Rhondalay Music (Los Angeles, USA) in 2015. Jazz artists, Kristina Kelman and Peter Walters were invited to challenge the traditional Christmas catalogue with an album of fresh and unique arrangements and originals. The album is a tribute to the late Frank Pooler, award-winning American choirmaster, and former Director of Choral Studies at California State University, Long Beach, and well-known for his collaborations with Richard and Karen Carpenter. The album includes a stylised, jazz re-invention of traditional songs such as Silver Bells, Carol of the Bells, O Christmas Tree and Let it Snow through mixed modes, changing time signatures, use of layering techniques, altered harmony, new forms, re-invention of melody and rhythm, improvisation and exploration of various styles, feels and instrumentation . Five original compositions exploring themes of family, loss and personal understandings of the theme of Christmas. The album was released internationally in December, 2015 and distributed both digitally and physically
A Phase I Trial of TGR-1202, a Next Generation Once-Daily PI3Kδ Inhibitor, in Combination with Brentuximab Vedotin, in Patients with Relapsed/Refractory Hodgkins Lymphoma
A Phase I Trial of TGR-1202, a Next Generation Once Daily PI3K-Delta Inhibitor in Combination with Obinutuzumab Plus Chlorambucil, in Patients with Chronic Lymphocytic Leukemia
Recommended from our members
O-0022 X-Pect Study Results: A Phase III Randomized Study of Perifosine Plus Capecitabine vs. Placebo Plus Capecitabine in Refractory mCRC Patients
Impact of PI3K aberrations on efficacy of perifosine (P), x-PECT: A phase III randomized study of P plus capecitabine (PC) versus placebo plus capecitabine (C) in refractory metastatic colorectal cancer (mCRC) patients.
Results of the X-PECT study: A phase III randomized double-blind, placebo-controlled study of perifosine plus capecitabine (P-CAP) versus placebo plus capecitabine (CAP) in patients (pts) with refractory metastatic colorectal cancer (mCRC).
LBA3501 The full, final text of this abstract will be available at abstract.asco.org at 12:01 AM (EDT) on Sunday, June 3, 2012, and in the Annual Meeting Proceedings online supplement to the June 20, 2012, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Sunday edition of ASCO Daily News